menu
    • menu

    Company profile for Pherecydes Pharma

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Pherecydes Pharma develops antibacterial treatments based on the use of bacteriophage viruses, or phages, to fight bacterial infections in humans, particularly those resistant to antibiotics. Phages are natural predators of bacteria and have no demonstrated effect on eukaryotic cells, including human cells. Antimicrobial resistant bacteria or AMR are responsible for over 700,000 death a year in 2014 according to the WHO. This...
    Pherecydes Pharma develops antibacterial treatments based on the use of bacteriophage viruses, or phages, to fight bacterial infections in humans, particularly those resistant to antibiotics. Phages are natural predators of bacteria and have no demonstrated effect on eukaryotic cells, including human cells. Antimicrobial resistant bacteria or AMR are responsible for over 700,000 death a year in 2014 according to the WHO. This number might reach over 10,000,000 by 2050 if nothing is done, and no new class of antibiotics has been discovered in the last 30 years.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Pherecydes PharmaFrance Flag
    Country
    Country
    France
    Address
    Address
    Nantes, Pays de la Loire
    Telephone
    Telephone
    +33 (0)1 41 50 62 04
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.pherecydes-pharma.com/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/pherecydes-pharma/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Global ChemShow

    Not Confirmed

    envelop Contact Supplier

    Global ChemShow

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Meet Phaxiam: Erytech's merger with Pherecydes is complete
    Meet Phaxiam: Erytech's merger with Pherecydes is complete

    26 Jun 2023

    // Max Bayer FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/erytechs-merger-pherecydes-reaches-finish-line-after-contentious-few-months

    Max Bayer FIERCE BIOTECH
    26 Jun 2023
    Share Share
    Erytech & Pherecydes Announce Merger And Name Change To Phaxiam Therapeutics
    Erytech & Pherecydes Announce Merger And Name Change To Phaxiam Therapeutics

    26 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/26/2694839/0/en/ERYTECH-and-PHERECYDES-announce-merger-and-name-change-to-PHAXIAM-Therapeutics.html

    GLOBENEWSWIRE
    26 Jun 2023
    Share Share
    ERYTECH announces that the Commercial Court has rejected Akkadian's request to postpone the vote on the merger with Pherecydes Pharma
    ERYTECH announces that the Commercial Court has rejected Akkadian's request to postpone the vote on the merger with Pherecydes Pharma

    14 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/14/2688418/0/en/ERYTECH-announces-that-the-Commercial-Court-has-rejected-Akkadian-s-request-to-postpone-the-vote-on-the-merger-with-Pherecydes-Pharma.html

    GLOBENEWSWIRE
    14 Jun 2023
    Share Share
    Activist investor aims to obstruct Erytech-Pherecydes merger
    Activist investor aims to obstruct Erytech-Pherecydes merger

    05 Jun 2023

    // James Waldron FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/erytech-accuses-investor-trying-destabilize-biotech-opposing-pherecydes-merger-vote

    James Waldron FIERCE BIOTECH
    05 Jun 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search